Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Linda Hanssens, MS, MSPH
JCP
Original Research
Predicted Risk of Diabetes and Coronary Heart Disease in Patients With Schizophrenia: Aripiprazole Versus Standard of Care
May 11, 2008
Lawrence Blonde
,
Hong J. Kan
,
Elane M. Gutterman
, et al
JCP
Article
Major Changes in Glucose Metabolism, Including New-Onset Diabetes, Within 3 Months After Initiation of or Switch to Atypical Antipsychotic Medication in Patients With Schizophrenia and Schizoaffective Disorder
March 14, 2008
Ruud van Winkel
,
Marc De Hert
,
Martien Wampers
, et al
JCP
Original Research
Treatment With Rosuvastatin for Severe Dyslipidemia in Patients With Schizophrenia and Schizoaffective Disorder
December 15, 2006
Marc De Hert
,
Dita Kalnicka
,
Ruud van Winkel
, et al
JCP
Original Research
Screening for Diabetes and Other Metabolic Abnormalities in Patients With Schizophrenia and Schizoaffective Disorder: Evaluation of Incidence and Screening Methods.
October 16, 2006
Ruud van Winkel
,
Marc De Hert
,
Dominique Van Eyck
, et al
